Cite

HARVARD Citation

    Ryan, A. et al. (n.d.). Comparative Nonclinical Assessments of the Proposed Biosimilar PF-05280586 and Rituximab (MabThera®). Toxicologic pathology. pp. 1069-1081. [Online]. 
  
Back to record